Yeah that one was a bit intensive...
2 weeks just to read it (had a few nights where I had to work my day job so couldn't devote much time to it)
1 week to summarise into my own thoughts
A number of hours for the final edit, a few typos went through but a lot of it is the silly HC editor's/program's fault.
The science is so compelling, the best part about it is that they will learn more about our MOA over time. When it gets appropriately peer reviewed it will be amazing to read more on how it works and the effect it can have. It's nice to be in our position, ie in the middle...on the left we see the Footballers and the ordinary every day people who suffer pain and their OA getting better, being able to walk without so much of a limp, being able to pick up their dropped cat in the kitchen and no longer needing the walls of the house for support...on the right we see the science talking, how it works underneath.
Mate I love this view.
- Forums
- ASX - By Stock
- PAR
- The PhD - NO and the DMOAD magic of iPPS
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
2.20%
!
46.5¢

The PhD - NO and the DMOAD magic of iPPS, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
46.5¢ |
Change
0.010(2.20%) |
Mkt cap ! $184.8M |
Open | High | Low | Value | Volume |
45.5¢ | 48.0¢ | 44.0¢ | $534.2K | 1.168M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5245 | 45.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
47.0¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5245 | 0.455 |
1 | 23000 | 0.450 |
1 | 15000 | 0.445 |
1 | 10000 | 0.440 |
1 | 17857 | 0.435 |
Price($) | Vol. | No. |
---|---|---|
0.470 | 10000 | 1 |
0.475 | 13560 | 2 |
0.480 | 110598 | 4 |
0.485 | 10000 | 1 |
0.490 | 18000 | 2 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online